X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (29114) 29114
Book Chapter (290) 290
Magazine Article (29) 29
Book / eBook (8) 8
Book Review (3) 3
Newsletter (3) 3
Dissertation (2) 2
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (22093) 22093
male (14727) 14727
cardiac & cardiovascular systems (13834) 13834
female (12654) 12654
middle aged (9421) 9421
heart failure (7986) 7986
aged (7743) 7743
animals (6290) 6290
mortality (5309) 5309
treatment outcome (5020) 5020
adult (4910) 4910
cardiology (4452) 4452
heart (4448) 4448
echocardiography (4432) 4432
risk factors (4267) 4267
left-ventricular dysfunction (3714) 3714
heart failure - drug therapy (3568) 3568
heart failure - physiopathology (3552) 3552
cardiovascular (3454) 3454
heart-failure (3307) 3307
care and treatment (3216) 3216
prognosis (3194) 3194
hypertension (3175) 3175
medicine & public health (3159) 3159
electrocardiography (2859) 2859
cardiomyopathy (2773) 2773
ventricular dysfunction, left - physiopathology (2740) 2740
time factors (2689) 2689
cardiac patients (2580) 2580
pharmacology & pharmacy (2503) 2503
myocardial-infarction (2489) 2489
rats (2487) 2487
follow-up studies (2437) 2437
heart attacks (2409) 2409
analysis (2405) 2405
peripheral vascular disease (2402) 2402
ventricular function, left - drug effects (2400) 2400
heart diseases (2368) 2368
prospective studies (2246) 2246
therapy (2220) 2220
ventricular dysfunction, left - drug therapy (2204) 2204
drug therapy (2178) 2178
cardiovascular disease (2176) 2176
dysfunction (2172) 2172
angiotensin-converting enzyme inhibitors - therapeutic use (2153) 2153
abridged index medicus (2080) 2080
health aspects (2017) 2017
research (2005) 2005
acute myocardial-infarction (1976) 1976
stroke volume (1943) 1943
ventricular function, left (1891) 1891
retrospective studies (1873) 1873
aged, 80 and over (1834) 1834
diagnosis (1769) 1769
myocardial infarction (1766) 1766
disease models, animal (1761) 1761
survival (1731) 1731
heart failure - therapy (1717) 1717
medicine, general & internal (1707) 1707
ventricular dysfunction, left - etiology (1666) 1666
disease (1633) 1633
blood pressure (1615) 1615
myocardium - pathology (1585) 1585
ventricle (1579) 1579
left-ventricular hypertrophy (1569) 1569
adrenergic beta-antagonists - therapeutic use (1540) 1540
cardiovascular diseases (1525) 1525
myocardial infarction - physiopathology (1517) 1517
myocardial infarction - drug therapy (1504) 1504
congestive-heart-failure (1486) 1486
patients (1470) 1470
risk (1440) 1440
internal medicine (1407) 1407
cardiac arrhythmia (1405) 1405
dilated cardiomyopathy (1405) 1405
surgery (1393) 1393
hypertrophy (1380) 1380
left-ventricular function (1378) 1378
physiology (1370) 1370
ventricular dysfunction, left - diagnostic imaging (1366) 1366
myocardium - metabolism (1351) 1351
heart failure - mortality (1332) 1332
hypertension - drug therapy (1324) 1324
heart failure - etiology (1321) 1321
ventricular function, left - physiology (1309) 1309
ejection fraction (1287) 1287
studies (1256) 1256
cardiology and cardiovascular medicine (1255) 1255
risk assessment (1240) 1240
heart failure - diagnosis (1239) 1239
heart attack (1227) 1227
ventricular remodeling - drug effects (1225) 1225
adolescent (1221) 1221
hemodynamics (1214) 1214
ischemia (1211) 1211
physiological aspects (1192) 1192
predictive value of tests (1189) 1189
blood pressure - drug effects (1159) 1159
atrial fibrillation (1152) 1152
management (1132) 1132
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (28853) 28853
German (216) 216
Russian (144) 144
French (124) 124
Spanish (100) 100
Japanese (84) 84
Portuguese (73) 73
Italian (65) 65
Polish (44) 44
Chinese (29) 29
Norwegian (14) 14
Czech (13) 13
Dutch (12) 12
Turkish (12) 12
Hungarian (11) 11
Danish (8) 8
Ukrainian (8) 8
Swedish (4) 4
Lithuanian (3) 3
Serbian (3) 3
Finnish (2) 2
Korean (2) 2
Slovak (2) 2
Arabic (1) 1
Croatian (1) 1
Hebrew (1) 1
Romanian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2011, Volume 364, Issue 17, pp. 1607 - 1616
Journal Article
Circulation (New York, N.Y.), ISSN 0009-7322, 07/2013, Volume 128, Issue 5, pp. 502 - 511
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 2017, Volume 69, Issue 22, pp. 2710 - 2720
.... Objectives The goal of this study was to determine the association between β-blocker use and mortality in patients with AMI without HF or left ventricular systolic dysfunction (LVSD... 
Cardiovascular | Internal Medicine | NSTEMI | preserved left ventricular systolic function | STEMI | average treatment effect | survival | propensity score | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | METOPROLOL | TRIAL | THERAPY | DISEASE | OUTCOMES | Heart Failure - complications | Myocardial Infarction - mortality | Prospective Studies | Survival Rate - trends | Follow-Up Studies | Ventricular Dysfunction - complications | Humans | Middle Aged | Ventricular Dysfunction - drug therapy | Male | Heart Failure - drug therapy | Dose-Response Relationship, Drug | Hospital Mortality - trends | Myocardial Infarction - complications | Propensity Score | Myocardial Infarction - drug therapy | Electrocardiography | Female | Registries | Aged | United Kingdom - epidemiology | Adrenergic beta-Antagonists - administration & dosage | Myocardial infarction | Heart attacks | Adjustment | Syngeneic grafts | Mortality | Cardiovascular disease | Coefficients | Patients | Survival | Beta blockers | Weighting | Ischemia | Risk assessment | Xenografts | Death | Fatalities | Infarction | Ventricle | Health risk assessment | Drug therapy | Heart diseases | PCI, percutaneous coronary intervention | CI, confidence interval | AMI, acute myocardial infarction | ATE, average treatment effect | STEMI, ST-segment elevation myocardial infarction | MINAP, Myocardial Ischaemia National Audit Project | LVSD, left ventricular systolic dysfunction | NSTEMI, non–ST-segment elevation myocardial infarction | HF, heart failure | Original Investigation
Journal Article
Circulation. Heart failure, ISSN 1941-3289, 01/2016, Volume 9, Issue 1, pp. e002661 - e002661
.... Whether a previously healthy person from a cardiovascular perspective develops cancer therapy-related cardiac dysfunction or a high-risk cardiovascular patient requires cancer therapy, the team... 
trastuzumab | heart failure | Anthracyclines | cardiotoxicity | ventricular dysfunction, left | cardiomyopathies | chemotherapy | VENTRICULAR EJECTION FRACTION | ADJUVANT CHEMOTHERAPY | LONG-TERM SURVIVORS | CARDIAC & CARDIOVASCULAR SYSTEMS | TRASTUZUMAB-INDUCED CARDIOTOXICITY | ventricular dysfunction | EUROPEAN ASSOCIATION | HER2-POSITIVE BREAST-CANCER | RENAL-CELL CARCINOMA | TROPONIN-I | left | anthracyclines | HIGH-DOSE CHEMOTHERAPY | AMERICAN-SOCIETY | Predictive Value of Tests | Prognosis | Humans | Heart Failure - physiopathology | Radiotherapy - adverse effects | Diagnostic Imaging - methods | Cardiomyopathies - physiopathology | Time Factors | Antineoplastic Agents - adverse effects | Cardiomyopathies - diagnosis | Neoplasms - radiotherapy | Heart Failure - diagnosis | Heart Failure - epidemiology | Risk Assessment | Comorbidity | Risk Factors | Radiation Injuries - diagnosis | Terminology as Topic | Treatment Outcome | Biomarkers - blood | Neoplasms - drug therapy | Radiation Injuries - epidemiology | Cardiomyopathies - epidemiology | Radiation Injuries - physiopathology | Heart Failure - chemically induced | Cardiomyopathies - chemically induced | treatment | cancer therapy | anthracycline | left ventricular dysfunction | cardiomyopathy | left ventricular ejection fraction
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 11/2010, Volume 56, Issue 20, pp. 1644 - 1650
Objectives: The purpose of this study was to examine treatment practices for cancer therapy-associated decreased left ventricular ejection fraction (LVEF... 
Heart failure | Left ventricular dysfunction | Anthracyclines | Chemotherapy | Cancer | ADJUVANT CHEMOTHERAPY | heart failure | CARDIAC & CARDIOVASCULAR SYSTEMS | RISK-FACTORS | TRASTUZUMAB | ADULTS | left ventricular dysfunction | chemotherapy | HER2-POSITIVE BREAST-CANCER | TRIAL COMPARING DOXORUBICIN | LYMPHOMA | cancer | anthracyclines | CONGESTIVE-HEART-FAILURE | HER2 | PLUS | Anthracyclines - adverse effects | Prognosis | Follow-Up Studies | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Antineoplastic Agents - therapeutic use | Heart Ventricles - diagnostic imaging | Ventricular Dysfunction, Left - chemically induced | Dose-Response Relationship, Drug | Young Adult | Antibodies, Monoclonal, Humanized | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Antineoplastic Agents - adverse effects | Ultrasonography | Adult | Female | Retrospective Studies | Adrenergic beta-Antagonists - therapeutic use | Risk Factors | Stroke Volume - drug effects | Ventricular Dysfunction, Left - physiopathology | Neoplasms - drug therapy | Ventricular Dysfunction, Left - drug therapy | Heart Ventricles - physiopathology | Aged | Anthracyclines - therapeutic use | Angiotensin Receptor Antagonists - therapeutic use | Trastuzumab | Breast cancer | Heart attacks | Drug therapy | Cancer therapies | Beta blockers | Leukemia | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2017, Volume 376, Issue 21, pp. 2032 - 2042
Journal Article
Circulation. Heart failure, ISSN 1941-3289, 02/2016, Volume 9, Issue 2, pp. 1 - 10
.... Cardiac toxicity, specifically the association of several cancer therapy agents with the development of left ventricular dysfunction and cardiomyopathy, is an issue of growing concern... 
Heart | Heart failure | Cardiomyopathies | Cardiotoxicity | Trastuzumab | VENTRICULAR SYSTOLIC DYSFUNCTION | heart failure | CARDIAC & CARDIOVASCULAR SYSTEMS | FOLLOW-UP | EUROPEAN ASSOCIATION | heart | CHEMOTHERAPY-INDUCED CARDIOMYOPATHY | trastuzumab | BREAST-CANCER | cardiotoxicity | INDUCED CARDIOTOXICITY | ANTHRACYCLINE-INDUCED CARDIOMYOPATHY | ASSOCIATION TASK-FORCE | cardiomyopathies | EXPERT CONSENSUS | AMERICAN-SOCIETY | Predictive Value of Tests | Humans | Heart Failure - physiopathology | Cardiomyopathies - prevention & control | Ventricular Dysfunction, Left - chemically induced | Heart Failure - prevention & control | Heart Failure - therapy | Ventricular Dysfunction, Left - therapy | Cardiomyopathies - physiopathology | Antineoplastic Agents - adverse effects | Cardiomyopathies - diagnosis | Heart Failure - diagnosis | Risk Factors | Ventricular Function, Left - drug effects | Treatment Outcome | Ventricular Dysfunction, Left - diagnosis | Critical Pathways | Ventricular Dysfunction, Left - physiopathology | Ventricular Dysfunction, Left - prevention & control | Cardiomyopathies - therapy | Algorithms | Animals | Heart Failure - chemically induced | Cardiomyopathies - chemically induced | Practice Guidelines as Topic | cancer therapy | anthracycline | cardiomyopathy | chemotherapy | cardiac failure
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2011, Volume 364, Issue 17, pp. 1617 - 1625
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2008, Volume 372, Issue 9641, pp. 807 - 816
Journal Article